LifeStance Therapists & Psychiatrists Grand Junction
743 Horizon Court, Suite 220, Grand Junction
4.5(203 Google reviews)
United States
5 listed treatment centers serving Grand Junction and the surrounding area.
743 Horizon Court, Suite 220, Grand Junction
4.5(203 Google reviews)
743 Horizon Court, 220, Grand Junction
5.0(37 Google reviews)
743 Horizon Court, 220, Grand Junction
4.9(30 Google reviews)
For people in Grand Junction considering SPRAVATO®, the most useful starting point is a benefits check with both the treatment center and the insurer. There is no single cost that applies to everyone. Your expenses depend on your coverage, the treatment setting, and how services are billed.
Both the medication and the supervised treatment and monitoring visit may generate charges. Ask for an estimate that includes all expected services—not just the nasal spray—and explains any deductible, copay, or coinsurance responsibilities.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials before deciding whether to approve treatment. Ask your prescribing clinician to help gather medication names, treatment dates, and information about your response or side effects. Confirm who submits the request and how you will learn the decision; submitting paperwork does not guarantee approval.
Medicare coverage may fall under Part B or Part D depending on the setting and plan. Colorado Medicaid coverage also depends on applicable program and plan requirements. Confirm both coverage and whether the treatment center accepts your insurance before scheduling.
Manufacturer savings programs exist for some eligible commercially insured patients, but not for people using government insurance. Ask about current eligibility rules and which charges a program may help with.
Before starting, ask:
There is currently no treatment center listed in Grand Junction in this directory. No other Colorado cities with listed centers are provided here, so we cannot point you to a verified nearby listing. This directory gap does not establish that treatment is unavailable locally. Ask your prescribing clinician or insurer to help locate a setting, then confirm directly that it is certified through the SPRAVATO® REMS program before making plans.
Spravato is not a take-home medication. You self-administer the nasal spray in a REMS-certified healthcare setting under a healthcare provider’s direct observation. Monitoring continues for at least two hours after each dose, and the full appointment may take longer for preparation and assessment before leaving.
The typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule appropriate for you; do not assume a fixed personal timeline.
Arrange for someone else to drive you home after every appointment. You must not drive or operate machinery until the next day after a restful sleep. Discuss acceptable transportation arrangements with the center before booking, including whether a support person needs to accompany you. Have a backup ride in case your original plan changes.
When planning time off work, allow for travel, preparation, monitoring, and recovery—not just the time spent taking the medication. If your work involves driving or machinery, discuss scheduling around that restriction. Ask about appointment availability early so you can coordinate rides, caregiving responsibilities, and repeat visits.
This directory currently has no listed treatment center in Grand Junction and no other listed Colorado cities to suggest. Ask your clinician or insurer for help finding a SPRAVATO® treatment setting. Before scheduling, confirm directly that the location is REMS-certified and currently offers treatment. Offering esketamine alone does not establish certification, and directory information should not substitute for that confirmation.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks to determine whether it is appropriate for you.
Coverage depends on your plan and the treatment setting. Prior authorization and documentation of earlier antidepressant trials are common requirements. Ask whether both the medication and the observed monitoring visit are covered and whether the center is in network. Medicare and Colorado Medicaid may cover treatment under applicable requirements, but neither coverage nor a center’s acceptance of your insurance should be assumed.
You administer the nasal spray yourself while a healthcare provider directly observes you in a REMS-certified setting. The team monitors you for at least two hours afterward, including for sedation, dissociation, breathing problems, and blood pressure increases. The full visit may take longer. You cannot take the medication home, and someone else must drive you home after the appointment.
Important risks include sedation, dissociation, respiratory depression, and increased blood pressure. Dissociation can involve feeling disconnected from yourself or your surroundings. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your health history and medications with the clinician, and promptly tell staff about symptoms during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Do not wait for a treatment consultation if you need urgent help. Call or text 988 for crisis support. If you are in immediate danger or experiencing a medical emergency, call 911.
Approved uses, nearby treatment centers, and medically sourced patient guides.